project id: TCGA-LUAD; case submitter id: TCGA-86-8674; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; age at index: 50; days to birth: -18479; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1962; age at diagnosis: 18479; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 806.0; icd 10 code: C34.2; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Middle lobe, lung; synchronous malignancy: No; tissue or organ of origin: Middle lobe, lung; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; cigarettes per day: 2.0547945205479454; pack years smoked: 37.5; years smoked: 30.0; is ffpe: false; weight: 38.0; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.5; longest dimension: 2.5; oct embedded: No; shortest dimension: 0.5; portion submitter id: TCGA-86-8674-01A-21; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 15.0; percent normal cells: 5.0; percent stromal cells: 10.0; percent tumor cells: 85.0; percent tumor nuclei: 70.0;